Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NVSEF - IPO Update: Virios Therapeutics Seeks $30 Million IPO

NVSEF - IPO Update: Virios Therapeutics Seeks $30 Million IPO

Novartis Ag Basel Akt
  • Virios Therapeutics has filed to raise $30 million in an IPO of its common stock.
  • The firm is developing a proprietary formulation for the treatment of fibromyalgia, a pain condition.
  • VIRI has achieved intriguing early efficacy results, received fast track review status and the IPO appears reasonably priced, so is worth considering.

For further details see:

IPO Update: Virios Therapeutics Seeks $30 Million IPO
Stock Information
Company Name: Novartis Ag Basel Akt
Stock Symbol: NVSEF
Market: OTC
Website: novartis.com
Menu
NVSEF NVSEF Quote NVSEF Short NVSEF News NVSEF Articles NVSEF Message Board
Get NVSEF Alerts

News, Short Squeeze, Breakout and More Instantly...